Inc. (NASDAQ: DAEG), a global information governance, migration
solutions and development tools company, today announced that it will
report fiscal 2015 third quarter financial results ended January 31,
2015, on Tuesday, February 24, 2015, after the market closes.
Petroleum Corporation (NYSE:OXY) announced today that at year-end
2014, the company's preliminary worldwide proved reserves totaled 2.82
billion barrels of oil equivalent (BOE) compared to 2.74 billion BOE at
the end of 2013, restated to exclude California Resources Corporation.
RedHill and Quest Diagnostics concluded a pre-submission meeting with U.S. FDA regarding RedHill's companion diagnostic test for the detection of MAP bacterium, an extension of RedHill's ongoing RHB-104 Phase III Crohn's disease development program Increasing evidence supports the hypothesis that Crohn's disease is caused by MAP infection in susceptible patients; Based of FDA's feedback, RedHill and Quest Diagnostics plan to commence a study to assess the clinical utility of the diagnostic test in Q2-Q3/2015 A protocol amendment for the ongoing Phase III study of RHB-104 in Crohn's disease has been filed with FDA and is expected to significantly increase the number of patients eligible to enroll in this study The RHB-104 Phase III MAP US study for Crohn's disease is one of RedHill's three ongoing Phase III studies in the U.S. with three of its drug candidates targeting gastrointestinal diseases
TEL-AVIV, Israel, Jan.
- Fourth-quarter sales up 2 percent over prior year despite currency - Fourth-quarter adjusted earnings of $0.65 per diluted share (EPS) up 35 percent from year-ago period
- Full-year 2014 adjusted EPS of $2.55, up 23 percent from 2013 - 2015 adjusted EPS estimated to be $2.65 to $2.75 NORTH CANTON, Ohio , Jan.
Shares of Coach (COH) jumped 8.6% in premarket trade Thursday, after the luxury accessories seller reported a better-than-expected fiscal second-quarter profit, and domestic sales that weren't as bad as forecast.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.